These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35281758)

  • 1. Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization.
    Majmundar M; Kansara T; Park H; Ibarra G; Marta Lenik J; Shah P; Kumar A; Doshi R; Zala H; Chaudhari S; Kalra A
    Int J Cardiol Heart Vasc; 2022 Apr; 39():100981. PubMed ID: 35281758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis.
    Borovac JA; Novak K; Bozic J; Glavas D
    Heart Vessels; 2019 Feb; 34(2):268-278. PubMed ID: 30159656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute lymphocyte count as a predictor of CD4 count.
    Shapiro NI; Karras DJ; Leech SH; Heilpern KL
    Ann Emerg Med; 1998 Sep; 32(3 Pt 1):323-8. PubMed ID: 9737494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure.
    Carubelli V; Bonadei I; Castrini AI; Gorga E; Ravera A; Lombardi C; Metra M
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):859-865. PubMed ID: 27541359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M
    JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Absolute Lymphocyte Count and Long-Term Mortality in Critically Ill Medical Patients: Propensity Score-Based Analyses.
    Hsiao YC; Shen PY; Wong LT; Chan MC; Chao WC
    Int J Gen Med; 2023; 16():3665-3675. PubMed ID: 37637708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early absolute lymphocyte count was associated with one-year mortality in critically ill surgical patients: A propensity score-matching and weighting study.
    Ho DT; Pham TT; Wong LT; Wu CL; Chan MC; Chao WC
    PLoS One; 2024; 19(5):e0304627. PubMed ID: 38814960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Lee MS; Duan L; Clare R; Hekimian A; Spencer H; Chen W
    Am J Cardiol; 2018 Aug; 122(3):405-412. PubMed ID: 30201108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
    Freiberg MS; Chang CH; Skanderson M; Patterson OV; DuVall SL; Brandt CA; So-Armah KA; Vasan RS; Oursler KA; Gottdiener J; Gottlieb S; Leaf D; Rodriguez-Barradas M; Tracy RP; Gibert CL; Rimland D; Bedimo RJ; Brown ST; Goetz MB; Warner A; Crothers K; Tindle HA; Alcorn C; Bachmann JM; Justice AC; Butt AA
    JAMA Cardiol; 2017 May; 2(5):536-546. PubMed ID: 28384660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry.
    Stolfo D; Uijl A; Benson L; Schrage B; Fudim M; Asselbergs FW; Koudstaal S; Sinagra G; Dahlström U; Rosano G; Savarese G
    Eur J Heart Fail; 2020 Jan; 22(1):103-112. PubMed ID: 31478583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement.
    Inohara T; Manandhar P; Kosinski AS; Matsouaka RA; Kohsaka S; Mentz RJ; Thourani VH; Carroll JD; Kirtane AJ; Bavaria JE; Cohen DJ; Kiefer TL; Gaca JG; Kapadia SR; Peterson ED; Vemulapalli S
    JAMA; 2018 Dec; 320(21):2231-2241. PubMed ID: 30512100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure.
    Durmus E; Kivrak T; Gerin F; Sunbul M; Sari I; Erdogan O
    Arq Bras Cardiol; 2015 Dec; 105(6):606-13. PubMed ID: 26536980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
    Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis.
    Zhang X; Sun Y; Zhang Y; Chen F; Zhang S; He H; Song S; Tse G; Liu Y
    Front Cardiovasc Med; 2021; 8():697221. PubMed ID: 34409076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.